Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Sponsor study identifier
Secondary identifiers
observational
2,085
1 country
1
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2013
Actual (reported)Study Completion
January 2013
Actual (reported)Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent COPD develops. This study will use data collected during the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) and its 33-year follow-up to determine the relationship between inflammatory protein expression and COPD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
October 31, 2006
Actual (reported)November 2, 2006
Actual (reported)January 2013
Actual (reported)January 2013
Actual (reported)COPD development defined as FEV1/FVC < 70%
up to 50 years
COPD progression defined based on decline of lung function
up to 50 years
Mortality
up to 50 years
Sample of the general population that was enrolled in 1972
Contact the study team to confirm eligibility.
Arizona Respiratory Center
Tucson, Arizona, 85724-5030, United States
DNA, serum, supernatants
Stefano Guerra, MD, PhD
Arizona Respiratory Center
2,085 participants (actual enrollment reported by the registry).
First Submitted
October 31, 2006
First Posted
November 2, 2006
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Thoracic Lymphatic Pump Techniques for Reducing Lung Volumes in Persons With Chronic Obstructive Pulmonary Disease
Primary Completion
January 2013
Actual (reported)Study Completion
January 2013
Actual (reported)Last Updated
December 6, 2017
Record last verified: 2017-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: